Revecore Acquires Kemberton and Cura, Creating One of the Leading Specialized Revenue Cycle Management Platforms in the Country

Revecore, a leading provider of revenue integrity and complex claims solutions for health systems, announced today that it has acquired two specialized revenue cycle management firms: Kemberton, based in Franklin, TN and Cherry Hill, NJ, and Cura Revenue Cycle Management, based in Tampa, FL. With these acquisitions, Revecore continues to execute on creating a leading portfolio of tech-enabled solutions to drive improved outcomes for health systems across the country. Dave Wojczynski, CEO of Revecore, will lead the combined entity.

“We are in a unique position to bring together firms that share our client-focused vision and value proposition of deploying a broad array of technology-driven solutions that optimize workflow to resolve the most complex claims and reimbursement challenges for health systems,” said Dave Wojczynski, Revecore’s CEO. “By combining efficient technology platforms with some of the industry’s most talented and experienced experts, we are well positioned to deliver greater value and recoveries to healthcare providers. We all share a culture of inclusion and a passion for serving our clients. This enhances our ability to collectively solve the most challenging revenue cycle issues. I am confident this strategic combination will result in even better financial outcomes for our clients.”

“The opportunity to combine these companies with complementary technologies and expertise is very compelling”

Read More: UiPath Named A Leader In The 2022 Gartner Magic Quadrant For Robotic Process Automation

“The opportunity to combine these companies with complementary technologies and expertise is very compelling,” said Mark McVeety, current CEO of Cura Revenue Cycle Management. “Revecore has an excellent track record in revenue integrity and complex claims solutions. We both have a client first culture, and I’m excited to continue to build on our joint capabilities and deliver results for our clients.”

“Teaming up with Revecore is a great next step in the evolution of the RCM industry,” said George Abatjoglou, current CEO of Kemberton. “With decades of experience and knowledge, the scale and capabilities of the combined organization will unlock greater opportunities to deliver best-in-class solutions that will not only benefit all of our combined clients but also enhance the patient-provider relationship.” LLR Partners is a current investor in Kemberton and will retain a minority equity interest in Revecore as a part of the transaction.

Read More: SalesTechStar Interview with Pedro Souza, Vice President of Customer Care at SmartBear

Revecore is supported by its institutional shareholders GrowthCurve Capital, which completed its acquisition of Revecore in April 2022, and Riverside Partners, which continues to be a significant investor in the business alongside GrowthCurve and management. Vignesh Aier, Head of Healthcare Investing at GrowthCurve Capital, commented on behalf of the investors, “We are excited to support Revecore in making these strategic acquisitions. We believe the capabilities, scale, and technologies these companies bring will help Revecore continue strengthening its position as a leading provider of specialized revenue cycle management services for the country’s leading health systems.”

Revecore, GrowthCurve, and Riverside Partners were advised by TripleTree as financial advisor; McDermott Will & Emory and Davis Polk as legal counsels; and Alvarez & Marsal as financial and operational advisor. Cura was represented by Robinson+Cole, and Kemberton was represented by Goodwin Proctor.